|
TMOD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.640700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.117900E-02 |
| Normal-vs-Stage2 |
1.482350E-01 |
| Normal-vs-Stage3 |
3.973000E-04 |
| Normal-vs-Stage4 |
1.155930E-04 |
| Stage1-vs-Stage2 |
9.966000E-01 |
| Stage1-vs-Stage3 |
2.846100E-02 |
| Stage1-vs-Stage4 |
2.016300E-02 |
| Stage2-vs-Stage3 |
1.696400E-01 |
| Stage2-vs-Stage4 |
1.364610E-01 |
| Stage3-vs-Stage4 |
7.541000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.257700E-03 |
| Normal-vs-AfricanAmerican |
1.150230E-04 |
| Normal-vs-Asian |
9.711200E-01 |
| Caucasian-vs-AfricanAmerican |
6.036000E-02 |
| Caucasian-vs-Asian |
3.132000E-01 |
| AfricanAmerican-vs-Asian |
8.551500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.433200E-04 |
| Normal-vs-Female |
6.359700E-03 |
| Male-vs-Female |
7.587000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.049000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.294000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.200340E-04 |
| Normal-vs-Age(81-100Yrs) |
7.577900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.965600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.632000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.022600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.105600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.270000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.072400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.147000E-01 |
| Normal-vs-Grade 2 |
5.949700E-02 |
| Normal-vs-Grade 3 |
2.17839999999692E-05 |
| Normal-vs-Grade 4 |
5.75280000000289E-05 |
| Grade 1-vs-Grade 2 |
1.497770E-01 |
| Grade 1-vs-Grade 3 |
2.842200E-03 |
| Grade 1-vs-Grade 4 |
3.920800E-03 |
| Grade 2-vs-Grade 3 |
7.599800E-03 |
| Grade 2-vs-Grade 4 |
5.056500E-03 |
| Grade 3-vs-Grade 4 |
3.207400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.535000E-01 |
| Normal-vs-ccB subtype |
2.175400E-03 |
| ccA subtype-vs-ccB subtype |
9.839900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.038200E-03 |
| Normal-vs-N1 |
6.122300E-02 |
| N0-vs-N1 |
7.058400E-01 |
|
|
